Trans-anal Irrigation (TAI) Market Size, Share & Trends 2030

Report Description

Trans-anal Irrigation (TAI) Market Outlook

The global Trans-anal Irrigation (TAI) market was estimated at USD 621.5 Million in 2021 and is anticipated to reach USD 864.4 Million by 2030, expanding at a CAGR of 3.8% during the forecast period. Patients who suffer from fecal incontinence or chronic constipation have irregular toilet patterns. Some people live in continual fear of loss of bladder control in public or having to spend hours in the restroom.

Anal washout or irrigation, a technique for cleaning the lower colon, aids in the treatment of chronic constipation and fecal incontinence. This kind of treatment is used only after the failure of less intrusive bowel control techniques. Numerous alternative systems are available; however, they all operate on the same principles.

Get Free Sample Report

Treatment options frequently involve dietary changes, bowel patterns, medication, fluid intake adjustments, evacuation strategies, and pelvic floor muscle training based on the individual's assessed symptoms. The National Institute for Health and Care Excellence (NICE) (2018) has approved trans-anal irrigation (TAI) as a treatment for constipation and fecal incontinence.

Trans-anal irrigation (TAI) is frequently used to control neurogenic bowel dysfunction (NBD). It is a preventative therapy rather than a treatment. Trans-anal Irrigation (TAI) helps with the evacuation of feces from the lower bowel. Through a particular device connected to a cone or rectal catheter put into the rectum, a significant amount of tepid tap water is injected into the large bowel.

The water helps to facilitate the evacuation of feces by gently stretching the intestine and softening the feces. It is safe to irrigate with water to empty the bowels. When traditional remedies such as diet, lifestyle modifications, and stool-modifying medication are ineffective, the use of trans-anal irrigation saves a lot of time and frustration.

Macro-economic Factors

Healthcare Spending

Governments across the globe are investing in the healthcare industry to increase real per capita healthcare spending. Healthcare expenditure plays an important role in the treatment of several diseases, owing to the high cost of treatments for different types of diseases. The average cost of a trans-anal irrigation procedure ranges from USD 8.0 to USD 367.0. 

According to National Health Estimates, the governmental share in total health expenditure increased from 28.6% in 2018 to 40.6% in 2019. National healthcare spending is expected to be USD 6.2 trillion in 2028. Thus, increasing healthcare spending across the globe is expected to boost the market in the coming years.

Technological Advancement

Major market players in almost every industry rely on the development of innovative products. Companies are focusing on investing in technologically advanced products and product development. Increasing expenditure on advancements in technology is leading to the development of products. For, instance, the trans-anal irrigation procedure (TAI) developed by B. Braun Medical Ltd, is equipped with new medical equipment called the IryPump R Set, which has an electric pump.

Trans-anal Irrigation (TAI) Market Dynamics

Market Drivers

• Rising prevalence of Colorectal Cancer and Inflammatory Bowel Diseases

The high prevalence of inflammatory bowel disorders and colorectal cancer is expected to boost the market in the coming years. Patients having these ailments require artificial anal irrigation, due to their fecal discharge issues. Anal irrigation systems help reduce chronic constipation and fecal incontinence, and control bowel syndrome. The surge in the number of colorectal cancer cases is anticipated to increase the demand for trans-anal irrigation systems.

The WCRF International reported more than 1.9 million new cases of colorectal cancer in 2020 globally, and that cancer is the third most common cancer globally. Similarly, between 25 million and 45 million people in the US have been diagnosed with inflammatory bowel diseases. Women aged between late adolescence and early 40s are mostly diagnosed with the ailment.

According to the International Foundation for Gastrointestinal Disorders, IBS is one of the most prevalent conditions diagnosed by doctors. Nearly 25% of people have severe IBS, 35% have moderate IBS, and 40% have mild IBS. Thus, the rising incidence of such disorders is expected to drive the market during the forecast period.

• Increasing Incidence of Neurogenic Bowel Dysfunction

Rising incidences of neurogenic bowel dysfunction are expected to boost the market during the forecast period. According to NCBI, the prevalence of neurogenic bowel dysfunction is over 2.5 million globally and an incidence of 15 per million in the UK. Trans-anal irrigation is recognized as a minimally invasive procedure with demonstrated clinical benefits, especially in patients with neurogenic bowel dysfunction disorders such as spinal cord injury, multiple sclerosis, and spina bifida.

The degree of spinal cord damage determines the amount of impairment in individuals with neurogenic bowel diseases, which result in loss of urge to urinate, reduces control over the external sphincter, causes loss of muscle tone and contractility in the bowel/rectum, and slow transit times. Trans-anal irrigation systems are more cost-effective in the long run than alternative therapies, recurrent tests, and hospital stays, despite their initial high price.

Market Restraint

• Lack of Awareness Among the Emerging Nations

Lack of awareness related to new-age medical devices, particularly in regions with less internet penetration and inefficient healthcare mechanisms, is anticipated to hinder the trans-anal irrigation market. The use of TAI systems is projected to be less, as they are commonly employed by the aged population in undeveloped countries Many governments provide reimbursement for TAI; however, few patients are aware of this option, which is likely to restrain the market during the forecast period.

• Possibility of Bowel Perforation

Fecal incontinence (involuntary leaking of solid or liquid stools) and chronic constipation are treated with rectal irrigation when other management strategies have failed. To remove the feces, warm water is injected into the rectum and lower (sigmoid) colon through the anus. As long as the patient follows the guidelines, rectal irrigation is relatively safe.

Patients who receive this treatment face a moderate chance of developing a perforation (hole) in the intestines. This risk reduces when the patient follows the advice offered by the healthcare provider. Other mild symptoms include a little bleeding, discomfort, nausea, and exhaustion developed during the treatment. These factors are expected to hinder the market in the coming years.

Scope of Trans-anal Irrigation (TAI) Market Report   

The report on the global Trans-anal Irrigation (TAI) market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Trans-anal Irrigation (TAI) Market Segmental Outlook

Based on type, the global Trans-anal Irrigation (TAI) market is segmented into cone system, balloon system, and bed system. The cone system segment is expected to expand at a CAGR of 3.6% during the forecast period, owing to an increase in patient compliance and easy procedure. The cone system is easy-to-use equipment for geriatric patients with less complication.

The balloon catheter segment accounts for a significant market share, due to rising cases of patients suffering from anal fissure conditions across the globe. In the US, around 2,50,000 people are diagnosed with cases of anal fissures. Thus, the high number of patients suffering from anal fissure conditions is propelling the demand for balloon catheters. According to the World Health Organization, the number of geriatric patients is projected to reach 426 million between 2020 and 2050.

Get Free Sample Report

On the basis of bowel dysfunction, the market is fragmented into irritable bowel syndrome (IBS), intestinal obstruction, and chronic constipation. The irritable bowel syndrome (IBS) segment is estimated to expand in the coming years, due to the rise in the number of patients with irritable bowel syndrome. As per the statistics published by the International Foundation for Gastrointestinal Disorders in 2007, 5% to 10% of the global population has IBS disorder. 25 million to 45 million people are affected by IBS in the US alone.

IBS patients prefer the use of balloon catheters and cone systems to treat this condition. The intestinal obstruction segment is projected to expand at a substantial pace, owing to an increase in research and development of balloon catheters to treat this condition. Various government bodies are investing their resources in clinical studies on the use of trans-anal ileus catheters for the treatment of malignant intestinal obstruction.

Thus, an increase in R&D investments for the development of balloon catheters used for intestinal obstruction has been registered. The chronic constipation segment is anticipated to expand at a CAGR of 3.9% during the forecast period, owing to the rising number of hospitalization and complications among patients with chronic constipation.

According to an article published by Johns Hopkins Medicine, around 4 million people in the US suffer from constipation. It is the most common GI problem, resulting in 2.5 million doctor visits annually. Thus, an increase in hospitalization of patients for chronic constipation propels the chronic constipation segment.

On the basis of application, the global trans anal irrigation (TAI) market is bifurcated into carried out on the toilet and carried out on the bed. The carried out on the toilet segment is projected to expand at a CAGR of 3.9% during the forecast periodThe carried out on the bed segment accounts for a significant share of the market, due to the rising number of neurogenic bowel dysfunction and spinal cord injury cases.

In 1997, the Journal of Neurology published data about the percentage of patients affected by neurological bowel dysfunction. An increase in the prevalence of neurological bowel dysfunction cases and a rise in the usage of bed systems to treat bowel dysfunction fuels the segment.

Get Free Sample Report

On the basis of end-user, the global trans-anal irrigation (TAI) market is bifurcated into children and adult. The children segment is anticipated to expand at a CAGR of 3.6% during the forecast period, owing to the rising incidence of functional constipation among children. The Department of Pediatric Gastroenterology published an article in 2017, which stated that about 3% of children suffer from functional constipation.

The rising number of patients suffering from functional constipation led to an increase in healthcare spending for the treatment of functional constipation. In 2009, the healthcare spending for functional constipation in the US was USD 3.9 million.

Regional Outlook

On the basis of region, the global trans anal irrigation (TAI) market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounts for 35.7% share of the market, due to the early adoption of new technologies. Wellspect HealthCare, a Dentsply Sirona Company, developed a product known as Navina Smart, a software-controlled electric pump that inflates a balloon catheter and helps in the removal of fecal matter in a controlled manner. The adoption of technologies in TAI devices propels the market in North America.

The market in Europe is anticipated to expand at a CAGR of 3.9% during the forecast period, as manufacturers of TAI devices are increasing research & development activities in these devices. The National Institute of Health and Care Excellence (NICE) published a program in 2009. This program invested its resources in the management of chronic constipation disorder. An increase in investment in such government programs boosts the market in Europe.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-depth Analysis of the Global Trans-anal Irrigation (TAI) Market
• Historical, Current, and Projected Market Size in Terms of Value
• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
• Industry Drivers, Restraints, and Opportunities Covered in the Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on Global Trans-anal Irrigation (TAI) Market Performance